JUNG CASSIE (Chief Operating Officer) sold 21.9% of their position (67.58K shares) of AQUESTIVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $473.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/17/2025ACC: 0001214659-25-015048
Officer· Chief Operating Officer
Since Mar 2026
-67.58K
Net shares
Net seller
$473.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 92.58K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
$3.10
Trade value
$77.57K
% of position
8.8%
10/15/2025
283.35K→308.35K
Common Stock
Direct
Shares
−67.58K
Price / share
$7.01
Trade value
$473.70K
% of position
21.9%
10/15/2025
308.35K→240.77K
Total
Net shares
−42.58K
Net value
-$396.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/15/2025 | M · Option Exercise | +25K | $3.10 | $77.57K | 8.8% | 283.35K | 308.35K |
| Common Stock Direct | 10/15/2025 | S · Sale | −67.58K | $7.01 | $473.70K | 21.9% | 308.35K | 240.77K |
| Total | −42.58K | -$396.13K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
3.1027
Held after
0.00
Exercisable
—
10/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock25K shares | 10/15/2025 | M · Option Exercise | −25K | 3.1027 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2K
Total
2K indirect2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Total | 2K | 2K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported